JOPP Award

The ISOPP/JOPP Best Paper Awards recognize articles published in the Journal of Oncology Pharmacy Practice (JOPP) since the last ISOPP Symposium that describe an innovation in oncology pharmacy practice (Oncology Pharmacy Practice Award) and scientific research (Oncology Clinical Research).

ISOPP/JOPP Oncology Pharmacy Practice Literature Award

This award recognizes an author who has written an article that contributes significantly to advancing the hematology/oncology pharmacy profession and describes innovations in community, hospital, or healthcare system hematology/oncology pharmacy practices. The innovations described should be applicable beyond the practice site and ideally on a global scale.

Oncology pharmacy practice refers to all aspects of professional practice, including administration, management, drug use control, technological services, clinical services, information processing, and new practice models.

ISOPP/JOPP Clinical Research Literature Award

This award recognizes an author who has written an important scientific article describing hematology/oncology clinical and/or translational research.

Eligible publications describe clinical research related to hematology/oncology pharmacy practice that use the formal scientific method. Some examples include: clinical effects of cancer treatment or supportive care medications; pharmacodynamic/pharmacokinetic/pharmacogenetic studies, “real-world” analyses of medication use; management of adverse effects; and, meta-analyses.

Award

The ISOPP/JOPP Best Paper Award recipients will be recognized at the ISOPP Symposia with a plaque.

Further details about award criteria and the application process will be coming soon. 

Past Recipients List 

2016

JOPP Best Paper Awards
Monoclonal antibodies: pharmacokinetics as a basis for new dosage regimens?
Authors: Jose R. Azanza, Belen Sadaba and Almudena Gomez-Guiu

JOPP Best Research Paper Award
The effects of a palliative care program on antidepressant use and continuing maintenance medications in near end-of-life oncology patients (the HEALED study)
Authors: Hillary Thomas, Monica Randolph and Jane Pruemer

2014

JOPP Research Award
A quantitative and qualitative method to control chemotherapeutic preparations by Fourier transform infrared–ultraviolet spectrophotometry 
Authors: Florian Dziopa, Guillaume Galy, Stéphanie Bauler, Benoit Vincent, Sarah Crochon, Mamadou Lamine Tall, Fabrice Pirot, Christine Pivot

JOPP Best Practice Award
Disintegration of chemotherapy tablets for oral administration in patients with swallowing difficulties
Authors: Rivka Siden & Matthew Wolf

2012

JOPP Research Award
Key components of intravenous chemotherapy labelling: a systematic review and practice guideline
Authors: Maureen Trudeau, Esther Green, Roxanne Cosby, Flay Charbonneau, Tony Easty, Yooj Ko, Patti Marchand, U David, Nadia Berger, Sherri Hertz

JOPP Best Practice Award
Cytotoxics compounded sterile preparation control by HPLC during a 16-month assessment in a French university hospital: importance of the mixing bags step
Authors: Vincent Castagne, Helene Habert, Chadi Abbara, Eric Rudant, Laurence Bonhomme-Faivre

2010

JOPP Research Award
Use of prescription and non-prescription medications and supplements by cancer patients during chemotherapy; questionnaire validation
Authors: Marie H Hanigan, Brian L. dela Cruz, David M. Thompson, Kevin C. Farmer, Patrick J. Medina

2008

JOPP Research Award
The incidence of extravasation of vinca alkaloids supplied in syringes or minibags
Authors: Peter Gilbar, Christine Carrington

JOPP Best Practice Award
Therapeutic drug monitoring of cancer chemotherapy
Author: Lamya Alnaim

2006

JOPP Research Award
Temozolomide for malignant gliomas in British Columbia; a population based cost-effectiveness analysis
Authors: E.D. Greanya, S.C.M. Taylor,  F. Hu,  J. Barnett,  B. Thiessen

JOPP Best Practice Award
Developing a targeted pharmacy oncology guide
Author: Dawn Annable

2004

JOPP Research Award
External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers
Authors: B. Favier B, L. Gilles, C. Ardiet, J.F.  Latour

JOPP Best Practice Award
Development of procedures to address health and safety issues in the administration of gene therapy within the clinical setting
Authors: N.S. Stoner, R.N.  Gibson, J. Edwards

2002

JOPP Research Award
Prospective evaluation of a policy of early discontinuation of antibiotics and discharge from hospital in children with cancer who develop fever
Authors: John T Wiernikowski, Ronal D. Barr, Ross Pennie

JOPP Best Practice Award
Establishing a baseline incidence of adverse drug reactions in hospitalized oncology patients
Authors: Susan Gaye Poole, Michael Joseph Dooley